(Q38049627)

27 August 2017

title

Vitamin D in multiple sclerosis: implications for assessment and treatment (English)

1 reference

27 August 2017

0 references

0 references

3

1 reference

27 August 2017

1

Trygve Holmøy

1 reference

27 August 2017

Margitta T Kampman

2

1 reference

27 August 2017

publication date

1 September 2012

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

27 August 2017

published in

1 reference

27 August 2017

volume

12

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

1101-1112

1 reference

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

27 August 2017

cites work

1 reference

Individual and joint action of environmental factors and risk of MS.

21 January 2018

1 reference

Vitamin D and multiple sclerosis

21 January 2018

1 reference

Vitamin D-gene interactions in multiple sclerosis.

21 January 2018

1 reference

Prevention and treatment of MS: studying the effects of vitamin D.

21 January 2018

1 reference

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

21 January 2018

1 reference

Vitamin D(3) is more potent than vitamin D(2) in humans

21 January 2018

1 reference

The multifunctional properties and characteristics of vitamin D-binding protein

21 January 2018

1 reference

Enzymes involved in the activation and inactivation of vitamin D.

21 January 2018

1 reference

21 January 2018

1 reference

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

21 January 2018

1 reference

Serum 25-hydroxyvitamin D concentrations fluctuate seasonally in young adults of diverse ancestry living in Toronto.

21 January 2018

1 reference

Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?

21 January 2018

1 reference

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

21 January 2018

1 reference

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

21 January 2018

1 reference

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

Relationship of UV exposure to prevalence of multiple sclerosis in England

21 January 2018

1 reference

Association of UV radiation with multiple sclerosis prevalence and sex ratio in France

21 January 2018

1 reference

Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.

21 January 2018

1 reference

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

21 January 2018

1 reference

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

Gestational vitamin D and the risk of multiple sclerosis in offspring

21 January 2018

1 reference

Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies

21 January 2018

1 reference

Confirmation of association between multiple sclerosis and CYP27B1

21 January 2018

1 reference

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

Rare variants in the CYP27B1 gene are associated with multiple sclerosis.

21 January 2018

1 reference

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

21 January 2018

1 reference

Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases

21 January 2018

1 reference

Vitamin D as an immune modulator in multiple sclerosis, a review

21 January 2018

1 reference

Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite

21 January 2018

1 reference

DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

21 January 2018

1 reference

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells

21 January 2018

1 reference

Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.

21 January 2018

1 reference

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

21 January 2018

1 reference

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis

21 January 2018

1 reference

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis

21 January 2018

1 reference

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.

21 January 2018

1 reference

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

21 January 2018

1 reference

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

Vitamin D in the healthy and inflamed central nervous system: access and function

21 January 2018

1 reference

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

21 January 2018

1 reference

Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line

21 January 2018

1 reference

Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: regulation by lipopolysaccharide and vitamin D.

21 January 2018

1 reference

1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons.

21 January 2018

1 reference

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

21 January 2018

1 reference

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.

21 January 2018

1 reference

Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.

21 January 2018

1 reference

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

21 January 2018

1 reference

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

21 January 2018

1 reference

Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?

21 January 2018

1 reference

Bone health in multiple sclerosis

21 January 2018

1 reference

Osteoporosis in multiple sclerosis

21 January 2018

1 reference

Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables

21 January 2018

1 reference

The risk of fracture in patients with multiple sclerosis: the UK general practice research database

21 January 2018

1 reference

Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers

21 January 2018

1 reference

Risk of fractures in patients with multiple sclerosis: a population-based cohort study.

21 January 2018

1 reference

Osteoporosis and its management

21 January 2018

1 reference

Diagnosis of osteoporosis in men, premenopausal women, and children

21 January 2018

1 reference

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

21 January 2018

1 reference

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

Vitamin D in African Americans with multiple sclerosis.

21 January 2018

1 reference

Vitamin D safety and requirements

21 January 2018

1 reference

Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml).

21 January 2018

1 reference

Estimates of optimal vitamin D status

21 January 2018

1 reference

Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients

21 January 2018

1 reference

Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults

21 January 2018

1 reference

Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients

21 January 2018

1 reference

21 January 2018

1 reference

Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients

21 January 2018

1 reference

Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial

21 January 2018

1 reference

Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15

21 January 2018

1 reference

Sun exposure and vitamin D are independent risk factors for CNS demyelination

21 January 2018

1 reference

Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals

21 January 2018

1 reference

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.12.99

1 reference

27 August 2017

1 reference